» Articles » PMID: 18152341

The Inhibition of Surface Phagocytosis by the Capsular Slime Layer of Pneumococcus Type III

Overview
Journal J Exp Med
Date 1949 Jul 1
PMID 18152341
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Five strains of type III pneumococcus have been shown to possess wide capsular slime layers during the logarithmic phase of growth in serum broth. The slime layer stains metachromatically with methylene blue and can be visualized under the electron microscope as a fuzzy halo which extends well beyond the surace of the capsule proper and causes centrifugates of the organism to be of extremely large volume. This outer capsular structure is most readily demonstrated in vivo and in nutrient broth containing glucose and serum. It disappears from the surface of the cell with aging of the culture, and is easily removed by dilute alkali, alcohol, and heat. Exposure of slime-covered type III pneumococci to homologous antibody and to type III polysaccharidase reveals that the slime layer contains the same type-specific polysaccharide that is present in the rest of the capsule. From a type III strain producing a prominent slime layer an intermediate mutant has been isolated which forms small non-mucoid colonies on blood agar and possesses a relatively small capsule with a barely discernible slime layer. The wide slime layer protects virulent type III pneumococci from surface phagocytosis. Whenever the type III cells lose their broad slime layer, whether from aging of the culture, from mutation, from exposure to injurious chemicals, or from the action of type III polysaccharidase, they become susceptible to phagocytosis by the surface mechanism. Once phagocyted the type III pneumococci are promptly destroyed, even in the absence of antibodies.

Citing Articles

Pathogenicity and virulence of : Cutting to the chase on proteases.

Marquart M Virulence. 2021; 12(1):766-787.

PMID: 33660565 PMC: 7939560. DOI: 10.1080/21505594.2021.1889812.


Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci.

Azarian T, Mitchell P, Georgieva M, Thompson C, Ghouila A, Pollard A PLoS Pathog. 2018; 14(11):e1007438.

PMID: 30475919 PMC: 6283594. DOI: 10.1371/journal.ppat.1007438.


Recent approaches in whole cell pneumococcal vaccine development: a review study.

Mohammadzadeh M, Mamishi S, Pourakbari B, Mahmoudi S Iran J Microbiol. 2018; 9(6):381-388.

PMID: 29487737 PMC: 5825939.


Importance of bacterial replication and alveolar macrophage-independent clearance mechanisms during early lung infection with Streptococcus pneumoniae.

Camberlein E, Cohen J, Jose R, Hyams C, Callard R, Chimalapati S Infect Immun. 2015; 83(3):1181-9.

PMID: 25583525 PMC: 4333471. DOI: 10.1128/IAI.02788-14.


Streptococcus pneumoniae phosphotyrosine phosphatase CpsB and alterations in capsule production resulting from changes in oxygen availability.

Geno K, Hauser J, Gupta K, Yother J J Bacteriol. 2014; 196(11):1992-2003.

PMID: 24659769 PMC: 4010992. DOI: 10.1128/JB.01545-14.


References
1.
Smith M, Wood W . STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMONIA DUE TO FRIEDLADER'S BACILLUS : III. THE ROLE OF "SURFACE PHAGOCYTOSIS" IN THE DESTRUCTION OF THE MICROORGANISMS IN THE LUNG. J Exp Med. 2009; 86(3):257-66. PMC: 2135725. DOI: 10.1084/jem.86.3.257. View

2.
DAWSON M . THE INTERCONVERTIBILITY OF "R" AND "S" FORMS OF PNEUMOCOCCUS. J Exp Med. 2009; 47(4):577-91. PMC: 2131392. DOI: 10.1084/jem.47.4.577. View

3.
WOOD Jr W, Smith M . Intercellular Surface Phagocytosis. Science. 1947; 106(2743):86-7. DOI: 10.1126/science.106.2743.86. View

4.
MUDD S, HEINMETS F, ANDERSON T . Bacterial Morphology as Shown by the Electron Microscope: VI. Capsule, Cell-Wall and Inner Protoplasm of Pneumococcus, Type III. J Bacteriol. 1943; 46(2):205-11. PMC: 373805. DOI: 10.1128/jb.46.2.205-211.1943. View

5.
Blake F, Trask J . Pneumococcus Variants Intermediate between the S and R Forms. J Bacteriol. 1933; 25(3):289-307. PMC: 533466. DOI: 10.1128/jb.25.3.289-307.1933. View